DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Dr. Lal Path Labs Ltd. — Board Meeting Intimation

NSE 1 hr ago·25 Sept 2026, 12:49 pm

DR. LAL Path Labs

Dr. Lal Path Labs has announced that its board will meet on November 4, 2026, to review and approve the company's unaudited financial results for the quarter ended September 2026. This is a standard procedural update that signals the company is nearing the end of its reporting cycle for the period.

For investors, this meeting is a key milestone as it will set the stage for the release of the quarterly earnings report. The results will likely provide insights into the company's financial health, operational performance, and growth trajectory in the healthcare diagnostics sector. Investors will be keen to see how the company is faring against its peers and market expectations.

Moving forward, market participants should focus on the actual earnings release for detailed insights. Key areas of interest will include revenue growth, margins, and any commentary from management regarding future business strategies. This data will be crucial for assessing the stock's short-term and long-term investment potential.